CLINICAL AND ECONOMIC IMPACT OF BLOOD CULTURES AMONG ADULT PATIENTS ADMITTED WITH PNEUMONIA IN TIANJIN, CHINA

Author(s)

Yu N1, Wu J1, Li P2
1Tianjin University, Tianjin, China, 2Becton, Dickinson and Company, Shanghai, China

OBJECTIVES: Blood culture (BC) is a key diagnostic technique detecting bloodstream infections (BSI) that is a life-threatening condition. It also establishes the infectious etiology and initiates further antimicrobial susceptibility testing and therapy optimization. The present study aimed to examine the clinical and economic impact of BC among patients with pneumonia, one of the commonest diseases complicated by BSI, in Tianjin. METHODS: A retrospective observational study was conducted in two tertiary hospitals. We aimed to identify 300 balanced consecutively hospitalized adult patients with pneumonia diagnosis whom BC was obtained before August, 2015. Data were collected about patients’ demographics, clinical features, BC results and antibiotic regimens from their medical records. The results and costs of BC as well as the comparison between definitive antibiotic regimens and empiric therapies; including switching, addition, discontinuation or any change in dosage were reported. Finally, the antibiotics cost savings due to changing to alternatives based on BC results were evaluated. RESULTS: From

Conference/Value in Health Info

2016-09, ISPOR Asia Pacific 2016, Singapore

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PMD4

Topic

Epidemiology & Public Health

Topic Subcategory

Disease Classification & Coding

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×